Research Site

Papenburg 26871

3 studies enrolling now · 6 studies all time

What they study most

Cardiovascular Disease, Chronic Heart Failure With Reduced Ejection Fraction (HFrEF), Diabetes Mellitus, Type 2, Heart Failure, Heart Failure and Impaired Kidney Function, Hyperkalemia

Studies at this site

• Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin — Recruiting now
• A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event — Recruiting now
• Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function — Recruiting now
• Tracking Treatment Pathways in Adult Patients With Hyperkalemia. — Completed
• Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure — Completed
• A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus — Completed